Clinical plausibility: peer-reviewed evidence demonstrating preserved insulin stability and improved patient confidence in extreme conditions, and Health-economic validation: independent confirmation ...
FDA granted a narrow indication for CFD-FOLR1, targeting impaired folate transport into the CNS that drives developmental delay, seizures, movement disorders, and autistic features in some patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results